Stay updated on Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial
Sign up to get notified when there's something new on the Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial page.

Latest updates to the Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial page
- Check7 days agoChange DetectedRevision: v3.4.3 was added; several study documents and IPD-sharing items were removed from the study record.SummaryDifference17%

- Check14 days agoChange DetectedCore study details, eligibility criteria, outcomes, and locations remain unchanged. The differences observed are limited to formatting/UI elements and a timestamp update.SummaryDifference0.1%

- Check21 days agoChange DetectedNo additions or deletions were described for this page in the provided input.SummaryDifference0.1%

- Check28 days agoChange DetectedRevision: v3.4.2 replaces the previous v3.4.1 on the page; no study data, results, or functionality are affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check36 days agoChange DetectedRevision bumped from v3.4.0 to v3.4.1 with no visible changes to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedUI and metadata changes include adding a Show glossary option and updating QC-related labels to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0' (with minor wording changes for No FEAR Act data). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial page.